ClinicalTrials.gg
RecruitingNCT07631468Updated Aug 19, 2026

PROspect Registry :Post Market Clinical Follow-up Study

An observational study in Breast Surgery, sponsored by Stryker Endoscopy. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Stryker Endoscopy (part of Stryker) · Observational

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
5,000
Ages
18 Years and older
Sex
All
01

Study summary

Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)

Read the detailed description

The purpose of this study is to leverage standard of care data on clinical outcomes following surgical procedures as indicated for each device.

  • Performance Objective: To collect clinical outcomes and Patient Reported Outcome Measures (PROMs) data (as applicable) on subjects that have undergone surgical breast procedures utilizing one or more Stryker devices.
  • Safety Objective: To collect data on safety events on the use of Stryker devices and/or related procedures
02

Conditions studied

  • Breast Surgery

Keywords

  • Breast surgery
03

In context

Lead sponsor

Stryker Endoscopy is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Patients who have undergone a surgical procedure using the Stryker device(s) who meet all of the eligibility criteria will be screened and enrolled by participating Investigators.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Subject was ≥ 18 years of age at the time of the surgery
  • Patients who have undergone breast surgical procedures using MOLLI, SPY-PHI, and/or SPY AGENT GREEN

Exclusion criteria

Exclusion Criteria:

  • Subjects who are less than 1-month post-intervention
  • Concurrent participation in an interventional clinical study at the time of initial surgery
  • Subjects whose surgery date was prior to January 2022.
  • Pregnant or lactating females at the time of initial surgery
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
5,000 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Breast Surgical Procedures

    Patients who have undergone breast surgical procedure (per product indications for use) using the Stryker device who meet all of the following criteria will be screened and enrolled by participating Investigators.

    Device: Standard of care treatment

Interventions

  • DeviceStandard of care treatment

    Subject has undergone breast surgical procedures using one of the study devices and meets eligibility criteria

06

What researchers measure

Primary outcomes

  1. Successful marker localization

    (proportion of MOLLI markers that are detected intraoperatively)

    Time frame: From the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)

  2. Marker retrieval success

    (proportion of procedures in which the MOLLI marker is removed within the surgical specimen)

    Time frame: From the start of surgery to completion of surgery for each participant (assessed intraoperatively, up to the duration of the surgical procedure, typically within the same day)

07

Study locations

2 of 2 sites recruiting
  • MD Baptist MD Anderson
    Jacksonville, Florida 32207, United States
    Recruiting
    • Mona Janfaza PI, MD · Contact
  • Tufts Medical Center
    Boston, Massachusetts 02111, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for May 2031, 59 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 20, 2026
First posted
Jun 8, 2026
StartActual
Jun 1, 2026
Primary completionEst.
May 1, 2031
CompletionEst.
Dec 1, 2031
Last update
Aug 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07631468
Lead sponsor
Stryker Endoscopy
Responsible party
Sponsor
First posted
Jun 8, 2026
Start date
Jun 1, 2026
Primary completion
May 1, 2031 (estimated)
Completion
Dec 1, 2031 (estimated)
Last update
Aug 19, 2026

Study contacts

Prajakta Sawwalakhe, MD
Contact
prajakta.sawwalakhe@stryker.com
16692077970
Colleen Roden
Contact
colleen.roden@stryker.com
9312672041

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion